Testing a new antibody drug in healthy adults
This trial tests a new investigational drug called CM383, which is a type of antibody (a protein that helps the immune system) possibly targeting brain plaque linked to Alzheimer's disease. It is an early-stage study in healthy volunteers to check safety and how the drug behaves in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 54 years old.
- You must be generally healthy.
- You cannot smoke more than 5 cigarettes per day.
- You must be willing to avoid alcohol during the study.
- You must not have a history of drug abuse.
- You must not have had major surgery or a severe injury in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new antibody drug called CM583 in healthy people to see if it is safe and how the body handles it. It may help treat conditions related to certain proteins involved in pain and inflammation.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.
This early-stage trial tests whether ABBV-1758, a new drug given by injection, is safe and effective for people with Alzheimer's disease. The drug targets amyloid, a protein that builds up in the brains of people with Alzheimer's.
This trial tests a new drug called CM559 in healthy people to see if it is safe. If you are between 18 and 60 years old and generally healthy, you may be able to join.
This study tests an investigational drug called BEY2153 for people with early Alzheimer's disease. It aims to see if the drug is safe and can help slow memory decline.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.